Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Higher-dose formulations of semaglutide (Wegovy, 2.4 mg weekly) and tirzepatide (Zepbound, up to 15 mg weekly) are approved specifically for chronic weight management in non-diabetic patients
People who abandon treatment in month two frequently do so believing the medication didn't work for them, when it hadn't yet reached the dose at which it was studied
Many clients notice a reduction in hunger and cravings, helping them eat smaller portions and feel fuller faster
Elastin fibres take time to reorganise
In a market crowded with subscription weight loss apps and automated dosing platforms, Prime Surgicare delivers individualized medical weight loss guided by a board-certified bariatric and metabolic surgeon
